Efficacy and safety of second‐line chemotherapy for patients with advanced non‐small cell lung cancer complicated by interstitial lung disease

Efficacy and safety of second‐line chemotherapy for patients with advanced non‐small cell lung cancer complicated by interstitial lung disease

Abstract Background Treatment of non‐small cell lung cancer (NSCLC) patients with interstitial lung disease (ILD) is limited because of the risk of its acute exacerbation (AE). Furthermore, the efficacy and safety of second‐line chemotherapy for these patients is unclear. Methods To investigate the...

Full description

Bibliographic Details
Main Authors: Kenji Otsuka, Hiroshi Nokihara, Atsushi Mitsuhashi, Ryohiko Ozaki, Yohei Yabuki, Hiroto Yoneda, Hirokazu Ogino, Yasuhiko Nishioka
Format: Article
Language:English
Published: Wiley 2022-11-01
Series:Thoracic Cancer
Subjects:
acute exacerbation
chemotherapy
interstitial lung disease
non‐small cell lung cancer
usual interstitial pneumonia pattern
Online Access:https://doi.org/10.1111/1759-7714.14645

Internet

https://doi.org/10.1111/1759-7714.14645

Similar Items